PR
Priyatham Reddy Chennareddy
About Priyatham Reddy Chennareddy
Data last updated:
Priyatham Reddy Chennareddy is a Director at Nuevo Therapeutics Private Limited (since 2013). The company operates in Pharma. Nuevo Therapeutics Private Limited reported revenue of ₹1.11 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuevo Therapeutics Private Limited U24232TG2013PTC085338 | Director | 10 Jan 2013 | 2013 | ₹1.11 Cr (FY 2025) | Active |
Board colleagues of Priyatham Reddy Chennareddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Geetha Reddy Channa | 06462259 | Nuevo Therapeutics Private Limited | Director |
| Mitra Puchhalapalli | 00631734 | Nuevo Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyatham Reddy Chennareddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyatham Reddy Chennareddy
Priyatham Reddy Chennareddy currently holds 1 directorship: Nuevo Therapeutics Private Limited (Director, since 10 Jan 2013, revenue ₹1.11 Cr (FY 2025)).
Priyatham Reddy Chennareddy was first appointed on 10 Jan 2013 as Director at Nuevo Therapeutics Private Limited.
The current boards of Priyatham Reddy Chennareddy's companies include Geetha Reddy Channa (Nuevo Therapeutics Private Limited), Mitra Puchhalapalli (Nuevo Therapeutics Private Limited).